Skip to main navigation
Skip to main content
KASL
Contact us
mobile search button
mobile menu button
Search
Advanced Search
ABOUT
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
Page Path
HOME
Search
Nilanga Nishad
WHERE t1.sid in(parameter_dbtbl_author like '%Nilanga Nishad%') and t1.xml_status <> 99
1
results for
"Nilanga Nishad"
Filter
Article category
Editorial (1)
Keywords
HK-660S (1)
Primary sclerosing cholangitis (1)
Small ductal PSC (1)
Publication year
2025 (1)
Keywords
HK-660S (1)
Primary sclerosing cholangitis (1)
Small ductal PSC (1)
Cancel
Close
Publication Year
2025 (1)
Cancel
Close
Funded articles
Cancel
Close
"Nilanga Nishad"
Editorial
Autoimmune liver disease
Challenges and innovations in primary sclerosing cholangitis clinical trials: Evaluating HK-660S and the path forward: Editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
Nilanga Nishad
Clin Mol Hepatol
2025;31(2):581-583.
Published online November 4, 2024
DOI:
https://doi.org/10.3350/cmh.2024.0942
PDF
Citations
Citations to this article as recorded by
Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
Woo Hyun Paik, Do Hyun Park
Clinical and Molecular Hepatology
.2025; 31(2): e158.
CrossRef
6,693
View
50
Download
1
Web of Science
1
Crossref
First
Prev
Page
of 1
Next
Last
×
TOP